How effective is the RSV vaccine during pregnancy and how does it work?

Health & Lifestyle
410

Listen to article (english)

Translate to Spanish or other 102 languages!

How safe and effective is the RSV vaccine during pregnancy? Image for illustration purposes
How safe and effective is the RSV vaccine during pregnancy? Image for illustration purposes

Medical News Today

- Advertisement -
  • RSV is a respiratory virus affecting about 64 million people around the world each year. 
  • While RSV symptoms may only feel like a common cold to adults and older children, it can be much more serious in older adults, babies, and young children. 
  • About 1.4 million children ages 0 to 6 months are hospitalized from RSV each year.
  • The CDC and American College of Obstetricians and Gynecologists both recommend pregnant people receive an RSV vaccine to help immunize their babies from the disease before they are born. 

Respiratory syncytial virus (RSV) is a respiratory virus causing infection in the lungs, nose, and throat.

Follow the link below to Medical News Today to read the full Story: 

https://www.medicalnewstoday.com/articles/how-safe-effective-is-rsv-vaccine-during-pregnancy

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Oral Health’s Influence on Subjective Psychological Well-Being in Older Adults
Next article
Dr. Jose L. Almeda’s Pioneering Work in Liver Transplantation

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

Study: Menopause Hormone Therapy Declines Nationwide Despite Proven Benefits

Hormone therapy use among women in the U.S. remains low, even though it's an effective treatment for many menopause symptoms, according to a new Mayo Clinic study published in Mayo Clinic Proceedings.
- Advertisement -